CARE — Execution
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
CARE — Cutting Alzheimer's Risk through Endocrinology — is a Wellcome Leap program within the organization's $50 million Women's Health initiative, targeting a reduction in women's lifetime risk of Alzheimer's disease through endocrine mechanisms. The program aims to cut women's lifetime risk of Alzheimer's disease in half, reducing risk for 330 million women globally. Research is organized across…
Reducing women's lifetime risk of Alzheimer's disease through endocrinology, targeting biomarker development, neuroimaging, and predictive modeling to reduce risk for 330 million women globally.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalGrant Proposal Sections: What Reviewers Expect in Each Part
A section-by-section guide to grant proposal format, project summaries, work plans, budgets, teams, letters of support, outcomes, and reviewer expectations.
Write proposalGrant Proposal Example: Sample Applications and What to Learn From Them
Learn how to use grant proposal examples, sample applications, and public funded proposals without copying weak structure or missing funder-specific rules.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
HOPE — Execution
Wellcome Leap · United States
Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.
Similar grants
Browse the directory →
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
ARPA-H Program ISOs (topic-specific)
🇺🇸ARPA-H · United States
Funds United States health initiatives through topic-focused pathways across multiple mission areas and agencies.